Blog

Meet: Chad Geringer

Chad Geringer recently joined biomodal and focuses on business development in North America.

15 August 2023

Blog

Meet: Aziz Mustafa

Dr Aziz Mustafa recently joined biomodal as our Director of Sales and Business Development for Europe.

We caught up with Aziz to learn more about him, his background, and what excites him about the field of epigenetics.

4 August 2023

Blog

Simultaneous sequencing of genetic and epigenetic bases in DNA

Two decades ago the Human Genome Project was completed. Since then, the first sequence of the human genome and subsequent population genomes have provided critical

26 July 2023

Blog

Investigating the link between loss of epigenetic information and ageing

In a recent paper published in Cell, researchers from Harvard Medical School investigated if loss of epigenetic information was a cause of ageing. To do

20 July 2023

Blog

Cancer: How DNA methylation will become a powerful tool for diagnosis and prognosis

In this article, we highlight three recent studies that showcase the power of methylation screening for the diagnosis and prognostic measurement of different types of

19 July 2023

News

biomodal launches solution to simultaneously sequence genetics and epigenetics in one workflow

biomodal (formerly known as Cambridge Epigenetix) commercially launches its new duet multiomics solution, revealing the combinatorial power of genetic and epigenetic information from a single

13 April 2023

News

New beginnings: becoming biomodal

It all started with an epigenetic discovery Since Cambridge Epigenetix began in 2012, we’ve been innovating in the field of DNA sequencing and epigenetics. Back

13 April 2023